ArticleBlood advances2021

Clinical, molecular, and prognostic comparisons between CCUS and lower-risk MDS: a study of 187 molecularly annotated patients.

Marissa Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.